POLYETHLENE GLYCOL MODIFICATIONS OF THYMOSIN ALPHA-1

Polyethylene glycol modifications of thymosin alpha 1 (Talpha 1-PEGs), their preparation process, the medicine composition containing them, and their application in the medicine for preventing and treating diseases related with immune deficiency and hypoimmunity, including hepatitis B, hepatitis C,...

Full description

Saved in:
Bibliographic Details
Main Authors ZHENG JIANQUAN, QI CHUNHUI, QIE JIANKUN, ZHOU WENXIA, LIU KELIANG, DONG SIJIAN, MA JINBO
Format Patent
LanguageEnglish
Published 03.09.2009
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:Polyethylene glycol modifications of thymosin alpha 1 (Talpha 1-PEGs), their preparation process, the medicine composition containing them, and their application in the medicine for preventing and treating diseases related with immune deficiency and hypoimmunity, including hepatitis B, hepatitis C, hepatoma, malignant melanoma, non-small cell lung cancer, SARS, and AIDS etc.
Bibliography:Application Number: US20060093240